Join
Live feed
·
INSIDERFilingvia Quantisnow
Bicycle Therapeutics plc logo

Director Swanton Robert Charles sold $872 worth of Ordinary Shares (102 units at $8.55), decreasing direct ownership by 0.65% to 15,487 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BCYC· Bicycle Therapeutics plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BCYC (Bicycle Therapeutics plc) and more on Quantisnow.